FDA Panel Recommends Easing Regulations on Peptides
A panel from the Food and Drug Administration (FDA) with connections to the industry recommended easing regulations on six peptides. This decision was made despite objections from FDA scientists who cited insufficient data. Peptides are touted for benefits like faster healing, improved skin appearance, and extended lifespan, though evidence supporting their effectiveness and safety is […]





